Studies support dexmedetomidine for ICU ventilation patients

03/22/2012 | MedPage Today (free registration)

Dexmedetomidine, a lighter sedative that does not have respiratory depressive effects, was as effective as midazolam or propofol for long-term sedation in ventilated ICU patients, Bern University researchers reported in two studies in the Journal of the American Medical Association. Data also showed dexmedetomidine may reduce the duration of ventilation and that patients were more easily aroused and better able to communicate with staff compared with those on midazolam.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI